Dr. Martin Earle, gives a presentation of the efficacy and safety of Pembrolizumab monotherapy in patients with previously treated advanced gastric cancer.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Illustrate the efficacy and safety of Pembrolizumab in advanced gastric cancer
  • Demonstrate the activity of FLOT, a new neoadjuvant chemotherapy, in potentially resectable gastric or GEJ cancers
  • Demonstrate the activity of Lenvatinib vs Sorafenib in advanced hepatocellular cancer

Reading Resources: 

  1. JCO 35, 2017, supp.  Abstract 4003
  2. JCO 35, 2017, supp. Abstract  4004
  3. JCO 35, 2017, supp. Abstract  4001

Disclosures:

Dr. Earle has reported no relevant relationships with any entities producing health care goods or services.

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement: 

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (.25) continuing education units (CEU) which are equivalent to .25 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at http://ccehs.upmc.com and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 10/6/2017 | Last Modified On: 10/6/2017 | Expires: 10/8/2018

take cme evaluation